Paloma Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-69,900
| Closed | -$6.94M | – | 2694 |
|
|
2019
Q3 | $6.94M | Sell |
69,900
-17,129
| -20% | -$1.63M | 0.14% | 115 |
|
|
2019
Q2 | $8.04M | Buy |
87,029
+21,799
| +33% | +$2.07M | 0.14% | 129 |
|
|
2019
Q1 | $6.15M | Buy |
65,230
+47,762
| +273% | +$4.18M | 0.15% | 123 |
|
|
2018
Q4 | $1.12M | Sell |
17,468
-129,397
| -88% | -$9.55M | 0.03% | 420 |
|
|
2018
Q3 | $13.1M | Buy |
146,865
+76,617
| +109% | +$6.77M | 0.24% | 56 |
|
|
2018
Q2 | $5.58M | Buy |
70,248
+52,954
| +306% | +$4.4M | 0.1% | 153 |
|
|
2018
Q1 | $1.54M | Sell |
17,294
-4,210
| -20% | -$404K | 0.02% | 728 |
|
|
2017
Q4 | $2.24M | Buy |
+21,504
| New | +$2.43M | 0.03% | 621 |
|
|
2017
Q3 | – | Sell |
-1,885
| Closed | -$257K | – | 2719 |
|
|
2017
Q2 | $245K | Sell |
1,885
-11,033
| -85% | -$1.35M | ﹤0.01% | 1898 |
|
|
2017
Q1 | $1.61M | Sell |
12,918
-18,427
| -59% | -$2.21M | 0.02% | 929 |
|
|
2016
Q4 | $3.63M | Buy |
31,345
+6,540
| +26% | +$728K | 0.04% | 378 |
|
|
2016
Q3 | $2.59M | Sell |
24,805
-80,930
| -77% | -$8.76M | 0.03% | 424 |
|
|
2016
Q2 | $10.4M | Sell |
105,735
-41,617
| -28% | -$4.3M | 0.11% | 99 |
|
|
2016
Q1 | $14.7M | Buy |
147,352
+143,910
| +4,181% | +$14.8M | 0.24% | 56 |
|
|
2015
Q4 | $412K | Sell |
3,442
-38,255
| -92% | -$4.43M | 0.01% | 1154 |
|
|
2015
Q3 | $4.51M | Buy |
41,697
+20,121
| +93% | +$2.5M | 0.1% | 127 |
|
|
2015
Q2 | $2.5M | Buy |
21,576
+15,765
| +271% | +$1.8M | 0.05% | 366 |
|
|
2015
Q1 | $669K | Sell |
5,811
-889
| -13% | -$106K | 0.02% | 658 |
|
|
2014
Q4 | $749K | Buy |
+6,700
| New | +$707K | 0.03% | 520 |
|
|
2014
Q3 | – | Sell |
-49,044
| Closed | -$4.21M | – | 1596 |
|
|
2014
Q2 | $4.21M | Buy |
49,044
+32,244
| +192% | +$2.45M | 0.17% | 133 |
|
|
2014
Q1 | $1.17M | Buy |
16,800
+10,910
| +185% | +$864K | 0.08% | 220 |
|
|
2013
Q4 | $497K | Sell |
5,890
-48,740
| -89% | -$3.86M | 0.02% | 589 |
|
|
2013
Q3 | $4.2M | Buy |
54,630
+51,126
| +1,459% | +$3.58M | 0.17% | 100 |
|
|
2013
Q2 | $205K | Buy |
+3,504
| New | +$211K | 0.01% | 921 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Paloma Partners's CELG Position: Q4 2019 in Review
Paloma Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 69,900 shares — an estimated $6.94M sold.
Paloma Partners first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $14.7M in Q1 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Paloma Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Paloma Partners sold 69,900 Celgene Corp shares in Q4 2019, an estimated $6.94M.
- Paloma Partners first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
- Paloma Partners's Celgene Corp position peaked at $14.7M in Q1 2016.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Paloma Partners's 13F filing for Q4 2019, filed 14 Feb 2020.